About half of patients with esophageal cancer presented with stage IV disease; 70.5 percent did not undergo surgical ...
News-Medical.Net on MSN
Ride Cincinnati grant funds research on immune activating wafer for glioblastoma treatment
A multidisciplinary team of University of Cincinnati Cancer Center researchers has received a $40,000 Ride Cincinnati grant to study a delayed release preparation, or wafer, of an immunostimulatory ...
Researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results